Status:
COMPLETED
Latanoprost Versus Fotil
Lead Sponsor:
Pharmaceutical Research Network
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.
Eligibility Criteria
Inclusion
- adults with primary open-angle or pigment dispersion glaucoma, or ocular hypertension
- untreated intraocular pressure should be between 24-36 mm Hg inclusive
- visual acuity should be 5/50 or better in both eyes
Exclusion
- presence of exfoliation syndrome or exfoliation glaucoma
- contraindications to study medications
- any anticipated change in systemic hypotensive therapy
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00304785
Start Date
May 1 2005
End Date
October 1 2007
Last Update
October 24 2007
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Gabinety Okulistyczne
Bydgoszcz, Poland, PL-85-670
2
Kierownik Kliniki Okulistycznej Akademii Medycznej
Poznan, Poland, PL-61-848
3
Instytut Jaskry
Warsaw, Poland, 00415
4
Katdra Klinika Okulityki Akademii Medycznej w Warszawie
Warsaw, Poland, 02-005